ATE199253T1 - Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen - Google Patents
Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionenInfo
- Publication number
- ATE199253T1 ATE199253T1 AT93401083T AT93401083T ATE199253T1 AT E199253 T1 ATE199253 T1 AT E199253T1 AT 93401083 T AT93401083 T AT 93401083T AT 93401083 T AT93401083 T AT 93401083T AT E199253 T1 ATE199253 T1 AT E199253T1
- Authority
- AT
- Austria
- Prior art keywords
- triazolones
- halophenylpiperazinyl
- antidepressant
- substituted
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/875,044 US5256664A (en) | 1992-04-28 | 1992-04-28 | Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE199253T1 true ATE199253T1 (de) | 2001-03-15 |
Family
ID=25365103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93401083T ATE199253T1 (de) | 1992-04-28 | 1993-04-26 | Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen |
Country Status (10)
Country | Link |
---|---|
US (1) | US5256664A (de) |
EP (1) | EP0568437B1 (de) |
JP (1) | JPH0641095A (de) |
AT (1) | ATE199253T1 (de) |
CA (1) | CA2094890C (de) |
DE (1) | DE69329942T2 (de) |
DK (1) | DK0568437T3 (de) |
ES (1) | ES2154644T3 (de) |
GR (1) | GR3035809T3 (de) |
PT (1) | PT568437E (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4425144A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Triazolverbindungen und deren Verwendung |
US6403593B1 (en) | 1995-07-14 | 2002-06-11 | Abbott Laboratories | Triazole compounds and the use thereof |
DE19728996A1 (de) | 1997-07-07 | 1999-01-14 | Basf Ag | Triazolverbindungen und deren Verwendung |
ES2152860B1 (es) * | 1998-10-23 | 2001-08-16 | Finaf 92 Sa | Forma cristalina de la nefazodona y procedimiento para su preparacion. |
EP1189616A2 (de) * | 1999-04-09 | 2002-03-27 | Sepracor Inc. | S-hydroxynefazodon |
US6469008B2 (en) | 1999-04-09 | 2002-10-22 | Sepracor Inc. | (R)-hydroxynefazodone antipsychotic therapy |
US6586437B2 (en) | 1999-04-09 | 2003-07-01 | Sepracor Inc. | (S)-hydroxynefazodone antipsychotic therapy |
JP2002541191A (ja) * | 1999-04-09 | 2002-12-03 | セプラコール, インク. | R−ヒドロキシネファゾドン |
JP3850224B2 (ja) | 2001-03-26 | 2006-11-29 | 株式会社ジェイテクト | 研削加工方法及び数値制御研削盤 |
US20030129186A1 (en) | 2001-07-25 | 2003-07-10 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
CA2356450C (en) * | 2001-09-10 | 2003-11-25 | Brantford Chemicals Inc. | An improved process for the preparation of nefazodone hydrochloride |
SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
EP2063905B1 (de) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen |
DK2398500T3 (da) | 2009-02-20 | 2019-05-13 | 2 Bbb Medicines B V | Glutathion-baseret lægemiddelafgivelsessystem |
ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
EP2919788A4 (de) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | Verfahren und zusammensetzungen zur behandlung von schizophrenie |
CN104402842A (zh) * | 2014-11-19 | 2015-03-11 | 苏州乔纳森新材料科技有限公司 | 一种哌嗪类药物中间体的合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4338317A (en) * | 1981-03-16 | 1982-07-06 | Mead Johnson & Company | Phenoxyethyl-1,2,4,-triazol-3-one antidepressants |
US4487773A (en) * | 1981-03-16 | 1984-12-11 | Mead Johnson & Company | 1,2,4-Triazol-3-one antidepressants |
US4386091A (en) * | 1982-02-24 | 1983-05-31 | Mead Johnson & Company | 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants |
US4613600A (en) * | 1983-09-30 | 1986-09-23 | Mead Johnson & Company | Antidepressant 1,2,4-triazolone compounds |
US5116852A (en) * | 1990-12-03 | 1992-05-26 | Bristol-Myers Squibb Co. | Treatment of sleep disorders |
-
1992
- 1992-04-28 US US07/875,044 patent/US5256664A/en not_active Expired - Lifetime
-
1993
- 1993-04-26 ES ES93401083T patent/ES2154644T3/es not_active Expired - Lifetime
- 1993-04-26 EP EP93401083A patent/EP0568437B1/de not_active Expired - Lifetime
- 1993-04-26 DE DE69329942T patent/DE69329942T2/de not_active Expired - Fee Related
- 1993-04-26 DK DK93401083T patent/DK0568437T3/da active
- 1993-04-26 AT AT93401083T patent/ATE199253T1/de not_active IP Right Cessation
- 1993-04-26 PT PT93401083T patent/PT568437E/pt unknown
- 1993-04-26 CA CA002094890A patent/CA2094890C/en not_active Expired - Fee Related
- 1993-04-27 JP JP5099931A patent/JPH0641095A/ja active Pending
-
2001
- 2001-04-27 GR GR20010400657T patent/GR3035809T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2094890C (en) | 2000-04-11 |
DE69329942D1 (de) | 2001-03-29 |
US5256664A (en) | 1993-10-26 |
GR3035809T3 (en) | 2001-07-31 |
EP0568437A1 (de) | 1993-11-03 |
JPH0641095A (ja) | 1994-02-15 |
ES2154644T3 (es) | 2001-04-16 |
CA2094890A1 (en) | 1993-10-29 |
EP0568437B1 (de) | 2001-02-21 |
PT568437E (pt) | 2001-06-29 |
DK0568437T3 (da) | 2001-04-30 |
DE69329942T2 (de) | 2001-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE199253T1 (de) | Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen | |
ATE180468T1 (de) | Anthranilsäure derivate | |
DE69817393D1 (de) | Neue heterozyklische verbindungen | |
CA2194503A1 (en) | 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use | |
DE69725978D1 (de) | Chalcon-derivate und medikamente die diese enthalten | |
ATE189814T1 (de) | Hydroxypyridin-derivate, ihre herstellung und ihre pharmazeutische verwendung | |
DE69428142D1 (de) | Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung | |
PT992509E (pt) | Novos derivados macrolidos | |
ATE186301T1 (de) | An den positionen 2 und 9 substituierte 4h-pyrido-(1,2-a)pyrimidin-4-one | |
PE34996A1 (es) | Nuevo derivado de pirrocarbazol | |
DK132188A (da) | Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika | |
ID23954A (id) | Tetrahidrogama-karbolin | |
ATE92489T1 (de) | Imid-derivate, ihre herstellung und verwendung. | |
NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
NO302821B1 (no) | Aminobenzosyrederivat, preparat omfattende derivatet og anvendelse av derivatet | |
ATE170851T1 (de) | Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten | |
BR0207966A (pt) | Composição farmacêutica contendo derivados 1,3-tiazina | |
DE69219219D1 (de) | Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl | |
DE69523819D1 (de) | Quinolin-Derivate und diese enthaltende pharmazeutische Zusammensetzungen | |
EP1227098A4 (de) | Triazolpurin-derivate, medikamentzusammensetzungen, die diese enthalten und mittel, die affinität zum adenosin a3rezeptor zeigen | |
EP0919233B8 (de) | Therapeutisches mittel zur behandlung von nierenerkrankungen | |
SE9901237D0 (sv) | Novel use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |